期刊文献+

高糖激活p38丝裂原活化蛋白激酶信号通路诱导CD8^+T淋巴细胞表达辅助性T淋巴细胞1型趋化因子受体3 被引量:2

CXC-chemokine receptor 3 expression in CD8^+ T cells is activated by high glucose-induced p38 mitogen-activated protein kinase signaling pathway
下载PDF
导出
摘要 目的探讨高糖对CD8+T淋巴细胞中辅助性T淋巴细胞(Th)1型趋化因子受体3(CXCR3)表达水平的影响及其可能的机制。方法体外不同浓度葡萄糖(5、10、25、50mmol/L)培养CD8+T淋巴细胞,检测其CXCR3mRNA及蛋白的表达水平变化。同时检测高糖环境下(50mmol/L葡萄糖)CD8+T淋巴细胞氧化应激信号通路相关蛋白P65、P38、细胞外信号调节蛋白激酶(ERK)、c-jun氨基末端激酶(JNK)蛋白表达及磷酸化水平,并观察使用相应抑制剂阻断各氧化应激信号通路对CXCR3mRNA及蛋白表达的影响。结果随着培养基中葡萄糖浓度的升高,5、10、25、50mmol/L葡萄糖处理的CD8+T淋巴细胞中CXCR3mRNA及蛋白表达水平逐渐升高,两两比较,差异均有统计学意义(P值均<0.05),该作用呈浓度依赖性增强。高糖组(50mmol/L葡萄糖)磷酸化的P65、P38、ERK、JNK表达水平均显著高于与正常组(5mmol/L葡萄糖,P值均<0.05)。加入P38信号通路抑制剂SB203580后,高糖环境下CD8+T淋巴细胞的CXCR3mRNA及蛋白的表达水平显著低于高糖组(P值均<0.05),至正常组水平(P值均>0.05);而加入P65信号通路抑制剂BAY11-7082、ERK信号通路抑制剂PD98059、JNK信号通路抑制剂SP600125后,高糖环境下CD8+T淋巴细胞的CXCR3mRNA及蛋白的表达水平仍显著高于正常组(P值均<0.05),与高糖组的差异无统计学意义(P值均>0.05)。结论高糖可能通过激活p38丝裂原活化蛋白激酶(p38MAPK)信号通路诱导CD8+T淋巴细胞表达CXCR3,参与糖尿病周围神经病变发病中CD8+T淋巴细胞的趋化过程。 Objective To investigate the impact of high glucose on the expression of CXC-chemokine receptor 3 (CXCR3) in CD8+ T cells and its possible mechanism. Methods CD8+ T cells were cultured with glucose at different concentrations (5, 10, 25 and 50 mmol/L) in vitro. The levels of mRNA and protein of CXCR3 were detected. The activity of oxidative stress signaling pathway of nuclear factor (NF)-κB p65, p38 mitogen- activated protein kinase (MAPK), extracellular signal-regulated kinase (ERK) and c-jun N-terminal kinase (JNK) in CD8+ T cells were measured in high glucose (50 mmol/L) environment. And the effect of oxidative stress on the expression of CXCR3 was assessed with the application of corresponding inhibitors. Results High glucose stimulated the expression of mRNA and protein of CXCR3 in CD8+ T cells in a concentration-dependent way. There were significant differences in the levels of mRNA and protein of CXCR3 between different concentrations of glucose (5, 10, 25 and 50 mmol/L, all P〈0. 05). The levels of NF-κB p65, p38 MAPK, ERK and JNK in 50 mmol/L glucose culture were significantly higher than those in 5 mmol/L glucose culture (all P〈0.05). SB203580, the inhibitor of P38 signaling pathway reduced the glucose-induced expression Call P〈0.05)of CXCR3 in CD8+ Tcells to the normal-glucose level (both P〉0. 05). But BAY11-7082, PD98059 and SP600125, the inhibitor of P65, ERK and JNK signaling pathway did not reduce the high expression (all P〈0. 05) of CXCR3 in CD8+ T cells in the environment of high glucose (50 mmol/L). Conclusion High glucose may induce the expression of CXCR3 by activating p38 MAPK signaling pathway in CD8+ T cells, which involve in the chemotaxis of CD8+ T cells in diabetic peripheral neuropathy.
出处 《上海医学》 CAS CSCD 北大核心 2013年第5期438-441,共4页 Shanghai Medical Journal
基金 上海市科学技术委员会自然科学基金(10ZR1439400) 上海市卫生局中医药科研基金(2012J022A)资助项目
关键词 2型糖尿病 糖尿病周围神经病变 CD8+T淋巴细胞 P38丝裂原活化蛋白激酶 辅助性T 淋巴细胞(Th)1型趋化因子受体3 Type 2 diabetes Diabetic peripheral neuropathy CD8+ T cells p38 mitogen-activated protein kinase CXO-chemokine receptor 3
  • 相关文献

参考文献11

  • 1KING G L. The role of inflammatory cytokines in diabetes and its complications[J]. J Periodontol, 2008, 79(8 Suppl) :1527-1534.
  • 2CALLAGHAN B C, CHENG H T, STABLES C L, et al. Diabetic neuropathy: clinical mani{estations and current treatments[J]. Lancet Neurol, 2012, 11(6) : 521-534.
  • 3TESFAYE S, SELVARAJAH D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy [J]. Diabetes Metab Res Rev, 2012, 28(Suppl 1) : 8-14.
  • 4张进,薛波,施弘,钱雪梅,刘芳.糖尿病周围神经病变危险因素分析[J].上海医学,2008,31(10):721-723. 被引量:21
  • 5YOUNGER D S, ROSOKLIJA G, HAYS A P, et al. Diabetic peripheral neuropathy: a clinicopathologic and immunohistoehemical analysis of sural nerve biopsies[J]. Muscle Nerve, 1996, 19(6): 722-727.
  • 6KOSACKA J, NOWICKI M, KLOTING N, et al. COMP- angiopoietin-1 recovers molecular biomarkers of neuropathy and improves vascularisation in sciatic nerve of oh/oh mice [J]. PLoS One, 2012, 7(3): e32881.
  • 7KORNIEJEWSKA A, MCKNIGHT A J, JOHNSON Z, et al. Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes[J]. Immunology, 2011, 132(4): 503-515.
  • 8JI Q, CASTELLI L, GOVERMAN J M. MHC class Irestricted myelin epitopes are cross-presented by Tip-DCs that promote determinant spreading to CD8+ T cells[J]. Nat Immunol, 2013, 14(3): 254-261.
  • 9COX M A, KAHAN S M, ZAJAC A J. Anti-viral CD8 T cells and the cytokines that they love[J]. Virology, 2013, 435(1) : 157-169.
  • 10MULLER M, CARTER S, HOFER M J, et al. Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCLll in neuroimmunity-a tale of conflict and conundrum[J]. Neuropathol Appl Neurobiol, 2010, 36(5): 368-387.

二级参考文献10

  • 1侯宁宁,邱明才.糖尿病神经病变中的免疫机制[J].国际内分泌代谢杂志,2007,27(1):68-69. 被引量:10
  • 2[2]Rith-Najarian S,Branchaud C,Beaulieu Oo et aL Reducing lower-extremity amputations due to diabetes.Application of the staged diabetes management approach in a primary care setting.J Faro Pract,1998,47:127-132.
  • 3[3]Lavery L A,Wunderlich R P,Tredwell J L.Disease management for the diabetic foot,effectiveness of a diabetic foot prevention program to reduce amputations and hospitalizations.Diabetes Res Clin Pract,2005,70:31-37.
  • 4[4]Perkins B A,Olaleye D,ginman B,et al.Simple screening tests for peripheral neuropathy in the diabetes clinic.Diabetes Care,2001,24:250-256.
  • 5[5]Olaleye D,Perkins B A,Bill V.Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic.Diabetes Res Clin Pract,2001,54,115-128.
  • 6[7]Chang W Y,Jiang Y D,Chuang L M,et al.Quantitative sensory testing and risk factors of diabetic sensory neuropathy.J Neurol,1999,246:394-398.
  • 7[8]haw J E,Hodge A M,de Courten M,et al.Diabetic neuropathy in Mauritius:prevalence and risk factors.Diabetes Res Clin Prsct,1998,42:131-139.
  • 8[10]Dyck P J,Davies J L,Wilson D M,et al.Risk factors for severity of diabetic polyneuropathy,intensive longitudinal as-sessment of the Rochester Diabetic Neuropathy Study cohort.Diabetes Care,1999,22:1479-1486.
  • 9[11]Obrosova I G,Li F,AbatanOI,etal.Roleof poly(ADP-ribose) polymernse activation in diabetic neuropathy.Diabetes,2004,53:711-720.
  • 10洪天配.关于HbA_1c测定全球标准化的共识[J].中国糖尿病杂志,2007,15(12):768-768. 被引量:8

共引文献20

同被引文献23

  • 1冯娟,王宪.高同型半胱氨酸血症促进动脉粥样硬化发生发展的炎症免疫机制[J].中国医学前沿杂志(电子版),2011,3(3):10-17. 被引量:30
  • 2Taglieri N, Kocnig W, Kaski JC. Cystatin C and cardiovascular risk [J]. Clinical Chemistry, 2009, 55(11): 1932-1943.
  • 3Aukrust P, Halvorsen B, Yndestad A, et al. Chemokines and cardio- vascular risk [J]. Arteriosclerosis, Thrombosis, and Vascular Biolo- gy, 2008, 28(11): 1909-1919.
  • 4Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China [J]. N Engl J Med, 2010, 362: 1090-1101.
  • 5Tang W, Lv Q, Chen X F, Zou J J, Liu Z M, Shi Y Q. CD8+ T cell-mediated cytotoxicity toward Schwann cells promotes diabetic peripheral neuropathy[J]. Cell Physiol Biochem, 2013,32 : 827 -837.
  • 6Feldman E L, Stevens M J, Thomas P K, Brown M B, Canal N, Greene D A. A practical two-step quantitative clinical and electrophysiological assessmentfor the diagnosis and staging of diabetic neuropathy [J]. Diabetes Care, 1994, 17: 1281-1289.
  • 7Haque M, Fino K, Lei F, Xiong X, Song J. Utilizing regulatory T cells against rheumatoid arthritis [J]. Front Oncol, 2014, 4: 209.
  • 8Xu W H, Zhang A M, Ren M S, Zhang X D, Wang F, Xu X C, et al. Changes of Treg-associated molecules on CIN+ CD25+ Treg cells in myasthenia gravis and effects of immunosuppressants[J]. J Clin Immunol,2012, 32 : 975-983.
  • 9Zhai N, Chi X, Li T, Song H, Li H, Jin X, et al. Hepatitis C virus core protein triggers expansion and activation of CD4+ CD25+ regulatory T cells in chronic hepatitis C patients[J]. Cell Mol Immunol, 2014 Dec 22. doi: 10. 1038/cmi. 2014. 119. [Epub ahead of print].
  • 10ZhaoL, Sun L, Wang H, Ma H, Liu G, Zhao Y. Changes of CD4+ CD25+ Foxp3+ regulatory T cells in aged BALB/c mice[J]. J Leukoc Biol, 2007, 81: 1386- 1394.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部